Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility.

[1]  J. C. Hinshaw,et al.  Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes , 2004, Cell.

[2]  Christoph Freiberg,et al.  Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. , 2003, Genome research.

[3]  H. Nikaido,et al.  AcrB Multidrug Efflux Pump of Escherichia coli: Composite Substrate-Binding Cavity of Exceptional Flexibility Generates Its Extremely Wide Substrate Specificity , 2003, Journal of bacteriology.

[4]  B. Stockwell,et al.  Biological mechanism profiling using an annotated compound library. , 2003, Chemistry & biology.

[5]  Eric D. Brown,et al.  High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate. , 2003, Bioorganic & medicinal chemistry letters.

[6]  E. Brown.  Screening in Academe: A Perspective on Implementation of University-Based Small Molecule Screening , 2003, Journal of biomolecular screening.

[7]  K D Kumble,et al.  Protein microarrays: new tools for pharmaceutical development , 2003, Analytical and bioanalytical chemistry.

[8]  T. Nagasu,et al.  Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly , 2003, Molecular microbiology.

[9]  R. Strausberg,et al.  From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.

[10]  J. Cronan,et al.  Long-term and homogeneous regulation of the Escherichia coli araBAD promoter by use of a lactose transporter of relaxed specificity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Kevan M Shokat,et al.  The emerging power of chemical genetics. , 2002, Current opinion in cell biology.

[12]  K. Poole.  Multidrug resistance in Gram-negative bacteria. , 2001, Current opinion in microbiology.

[13]  M. Page,et al.  Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance Development , 2001, Antimicrobial Agents and Chemotherapy.

[14]  B. Stockwell.  Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.

[15]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[16]  H. Burger,et al.  A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin. , 2000, Biochemical and biophysical research communications.

[17]  S. Beverley,et al.  Isolation of Genes Mediating Resistance to Inhibitors of Nucleoside and Ergosterol Metabolism in Leishmania by Overexpression/Selection* , 1999, The Journal of Biological Chemistry.

[18]  P. Schultz,et al.  Opportunities at the interface of chemistry and biology. , 1999, Trends in cell biology.

[19]  T. Furuchi,et al.  Overexpression of L‐glutamine:D‐fructose‐6‐phosphate amidotransferase provides resistance to methylmercury in Saccharomyces cerevisiae , 1999, FEBS letters.

[20]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[21]  Elizabeth A. Winzeler,et al.  Genomic profiling of drug sensitivities via induced haploinsufficiency , 1999, Nature Genetics.

[22]  W. Bishai,et al.  Novel Selection for Isoniazid (INH) Resistance Genes Supports a Role for NAD+-Binding Proteins in Mycobacterial INH Resistance , 1998, Infection and Immunity.

[23]  A. Hinnen,et al.  Drug‐induced phenotypes provide a tool for the functional analysis of yeast genes , 1998, Yeast.

[24]  M. Raymond,et al.  Identification of Saccharomyces cerevisiae Genes Conferring Resistance to Quinoline Ring-Containing Antimalarial Drugs , 1998, Antimicrobial Agents and Chemotherapy.

[25]  E J Licitra,et al.  A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[27]  J. Hearst,et al.  Molecular cloning and characterization of acrA and acrE genes of Escherichia coli , 1993, Journal of bacteriology.

[28]  R. Kolter,et al.  Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase , 1992, Journal of bacteriology.

[29]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[30]  D. Botstein,et al.  Isolation, cloning, and sequencing of the Salmonella typhimurium ddlA gene with purification and characterization of its product, D-alanine:D-alanine ligase (ADP forming). , 1988, Biochemistry.

[31]  S. Cohen,et al.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. , 1980, Journal of molecular biology.

[32]  J. Rood,et al.  Cloning of the Escherichia coli K-12 dihydrofolate reductase gene following mu-mediated transposition. , 1980, Gene.

[33]  L. Clarke,et al.  Biochemical construction and selection of hybrid plasmids containing specific segments of the Escherichia coli genome. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Grant W. Brown,et al.  Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways , 2004, Nature Biotechnology.

[35]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.